NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.
Napigen's investors include RA Capital Management, SVG Ventures, Breakout Labs, U.S. Department of Agriculture, Grantham Foundation.
Napigen is headquartered in Wilmington, United States.
NAPIGEN is a biotechnology company that addresses novel genome engineering of various organisms such as plants, microbes, and animals.
Napigen is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Napigen — Funding & Investors." VCBacked, March 11, 2024, https://www.vcbacked.co/company/napigen. Accessed September 30, 2026.
VCBacked. (2024). Napigen — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/napigen
{{cite web |title=Napigen — Funding & Investors |url=https://www.vcbacked.co/company/napigen |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated